Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

PerkinElmer's $400 Mil. NEN Buy Highlights Build In Genomics M&A Activity

This article was originally published in The Gray Sheet

Executive Summary

Acquisition of NEN Life Sciences from the private equity investment firm Genstar Capital LLC for approximately $400 mil. will expand PerkinElmer's life sciences business and broaden the company's functional genomics and high-throughput screening offerings.

You may also be interested in...



LJL Biosystems, Inc.

Sunnyvale, California maker of genomics instruments and consumables withdraws previously planned follow-on stock offering of 2.9 mil. shares on April 10, citing "current market conditions"

EG&G/PE Corp.

EG&G completes $425 mil. acquisition of PE's Analytical Instruments business and gains rights to the "Perkin-Elmer" brand name, PE Corp. reports June 1. Announced March 8, the deal consists of $275 mil. in cash and $150 mil. in EG&G debt bearing a 5% coupon having a one-year maturity ("The Gray Sheet" March 15, p. 4)

Claim That Supplement Boosts Children’s Focus Could Spur FTC Attention

Creekside Natural Therapeutics might hear from the FTC after failing to show in an industry self-regulation forum that it would correct misleading claims for its Focused Mind Jr. supplement promoted as an alternative to ADHD drugs.
UsernamePublicRestriction

Register

MT013525

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel